Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Placental inflammation's role in adult depression and heart disease

An expression signature related to inflammation expressed in Hofbauer cells in the placenta, calculating polygenic risk scores to predict its expression.

14 Nov 2023

Study shows environment's pivotal role in healthy aging and disease prevention

Study explores new geroscience tools for studying the impact of environmental factors on aging, aiming to delay age-related diseases and disabilities. It highlights how non-genetic factors, like environmental toxins and socio-economic conditions, significantly influence aging and health outcomes.

13 Nov 2023

Multi-faceted implementation strategy significantly lowers blood pressure in low-income patients

Uncontrolled hypertension, the leading preventable risk factor for cardiovascular disease and premature deaths worldwide, disproportionately affects low-income populations.

13 Nov 2023

Automated referrals to pharmacy services dramatically increase appropriate statin prescription rates

The odds of prescribing the appropriate dose of statins - a medicine used to lower "bad" cholesterol levels - increased sixfold when automated referrals were made to pharmacy services, instead of relying on traditional prescribing methods, according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

13 Nov 2023

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

An intensive three-year intervention to lower the top blood pressure number to less than 120 mm Hg was more effective at preventing death, heart attack, stroke and other cardiovascular events in adults at high risk for cardiovascular disease, compared to the standard treatment target of under 140 mm Hg, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Intensive blood pressure control reduces dementia risk in adults with hypertension

An intensive, four-year blood-pressure intervention significantly reduced the risk of developing dementia among adults with high blood pressure compared to people who received usual care, in a study reported as late-breaking science today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Recaticimab injection every 1-3 months may safely lower bad cholesterol

A new PCSK9 inhibitor (recaticimab) injected every one to three months may work safely and provide more flexible dosing to lower cholesterol, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

Single injection of new medication effectively eliminates Lp(a) for nearly one year

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2023.

13 Nov 2023

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.

13 Nov 2023

Food allergies may be linked to increased cardiovascular death risk, study finds

Sensitivity to common food allergens such as dairy and peanuts could be an important and previously unappreciated cause of heart disease, new research suggests – and the increased risk for cardiovascular death includes people without obvious food allergies.

13 Nov 2023

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

A new calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to a new American Heart Association Scientific Statement published today in the Association's flagship journal Circulation.

10 Nov 2023

Brazzein and monellin: Safe alternatives to sugar, new research confirms

Toxicity assessments of monellin and brazzein.

10 Nov 2023

Diverse plant-based diets emerge as key to combating non-communicable diseases and climate change

The health and environmental benefits conferred by plant-based diets.

10 Nov 2023

Debate intensifies over vegan diets for children, pediatric associations weigh in

Evidence on vegan (VN) diets for pediatric and adolescent individuals.

10 Nov 2023

Is obesity an independent risk factor for cardiovascular disease?

Researchers explore how obesity contributes to cardiovascular disease by investigating this association in low-risk people.

10 Nov 2023

Study finds even small changes in movement patterns can improve heart health

The study, supported by the British Heart Foundation (BHF) and published in the European Heart Journal, is the first to assess how different movement patterns throughout the 24-hour day are linked to heart health.

9 Nov 2023

New study links food allergies to increased risk of heart disease death

Sensitivity to common food allergens such as cow's milk and peanuts could be an important and previously unappreciated cause of heart disease, new research suggests – and the increased risk for cardiovascular death includes people without obvious food allergies.

9 Nov 2023

UK Biobank study links social connections with reduced all-cause and cardiovascular mortality

The associations between functional and structural components of social connection and all-cause and CVD mortality.

9 Nov 2023

Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespan

Scientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population and their association with lifespan.

8 Nov 2023

Positive antiphospholipid antibodies linked to increased cardiovascular risk in lupus patients

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE).

7 Nov 2023

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Placental inflammation's role in adult depression and heart disease

Study shows environment's pivotal role in healthy aging and disease prevention

Multi-faceted implementation strategy significantly lowers blood pressure in low-income patients

Automated referrals to pharmacy services dramatically increase appropriate statin prescription rates

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

Intensive blood pressure control reduces dementia risk in adults with hypertension

Recaticimab injection every 1-3 months may safely lower bad cholesterol

Single injection of new medication effectively eliminates Lp(a) for nearly one year

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Food allergies may be linked to increased cardiovascular death risk, study finds

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

Brazzein and monellin: Safe alternatives to sugar, new research confirms

Diverse plant-based diets emerge as key to combating non-communicable diseases and climate change

Debate intensifies over vegan diets for children, pediatric associations weigh in

Is obesity an independent risk factor for cardiovascular disease?

Study finds even small changes in movement patterns can improve heart health

New study links food allergies to increased risk of heart disease death

UK Biobank study links social connections with reduced all-cause and cardiovascular mortality

Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespan

Positive antiphospholipid antibodies linked to increased cardiovascular risk in lupus patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in